BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 1389931)

  • 1. Pharmacodynamics of venlafaxine evaluated by EEG brain mapping, psychometry and psychophysiology.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Semlitsch HV; Magni G
    Br J Clin Pharmacol; 1992 Jun; 33(6):589-601. PubMed ID: 1389931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative pharmacodynamic studies with the novel serotonin uptake-enhancing tianeptine and -inhibiting fluvoxamine utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; Zyhlarz G
    J Neural Transm (Vienna); 1996; 103(1-2):191-216. PubMed ID: 9026373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG brain mapping and psychometry in age-associated memory impairment after acute and 2-week infusions with the hemoderivative Actovegin: double-blind, placebo-controlled trials.
    Saletu B; Grünberger J; Linzmayer L; Anderer P; Semlitsch HV
    Neuropsychobiology; 1990-1991; 24(3):135-48. PubMed ID: 2135068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative placebo-controlled pharmacodynamic studies with zotepine and clozapine utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Anderer P
    Pharmacopsychiatry; 1987 Feb; 20(1 Spec No):12-27. PubMed ID: 2883677
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: I. Double-blind, placebo-controlled EEG mapping and psychometric studies under normoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):55-66. PubMed ID: 8721257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early clinical pharmacological trials with a novel partial benzodiazepine agonist/antagonist Ro 17-1812 using pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1986 Jun; 8(6):373-89. PubMed ID: 3736281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. On central effects of serotonin re-uptake inhibitors: quantitative EEG and psychometric studies with sertraline and zimelidine.
    Saletu B; Grünberger J; Linzmayer L
    J Neural Transm; 1986; 67(3-4):241-66. PubMed ID: 2949057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visualizing central effects of S-adenosyl-L-methionine (SAMe), a natural molecule with antidepressant properties, by pharmaco-EEG mapping.
    Saletu-Zyhlarz GM; Anderer P; Linzmayer L; Semlitsch HV; Assandri A; Prause W; Hassan Abu-Bakr M; Lindeck-Pozza E; Saletu B
    Int J Neuropsychopharmacol; 2002 Sep; 5(3):199-215. PubMed ID: 12366873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind, placebo-controlled pharmacodynamic studies with a nutraceutical and a pharmaceutical dose of ademetionine (SAMe) in elderly subjects, utilizing EEG mapping and psychometry.
    Arnold O; Saletu B; Anderer P; Assandri A; di Padova C; Corrado M; Saletu-Zyhlarz GM
    Eur Neuropsychopharmacol; 2005 Oct; 15(5):533-43. PubMed ID: 16046102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and -dynamic studies with a new anxiolytic, suriclone, utilizing EEG mapping and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Semlitsch HV; Anderer P; Chwatal K
    Br J Clin Pharmacol; 1994 Feb; 37(2):145-56. PubMed ID: 7910470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of the novel neuroprotective agent, riluzole, on human brain function and behavior: II. Double-blind, placebo-controlled EEG mapping and psychometric studies under hypoxia.
    Saletu B; Grünberger J; Anderer P; Linzmayer L
    Methods Find Exp Clin Pharmacol; 1996; 18(1):67-81. PubMed ID: 8721258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic and dynamic studies with a new anxiolytic imidazo-pyridine alpidem utilizing pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L
    Int Clin Psychopharmacol; 1986 Apr; 1(2):145-64. PubMed ID: 2883214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute and subacute CNS effects of milacemide in elderly people: double-blind, placebo-controlled quantitative EEG and psychometric investigations.
    Saletu B; Grünberger J; Linzmayer L
    Arch Gerontol Geriatr; 1986 Oct; 5(3):165-81. PubMed ID: 3541816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Classification and determination of the pharmacodynamics of a new tetracyclic antidepressive agent, pirlindol, using pharmaco-EEG and psychometry].
    Saletu B; Grünberger L; Linzmayer L; Wittek R; Stöhr H
    Wien Klin Wochenschr; 1983 Jul; 95(14):481-93. PubMed ID: 6356628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the central effects of a new partial benzodiazepine agonist Ro 16-6028 in man: pharmaco-EEG and psychometric studies.
    Saletu B; Grünberger J; Linzmayer L
    Int J Clin Pharmacol Ther Toxicol; 1989 Feb; 27(2):51-65. PubMed ID: 2921096
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacodynamic studies on the central mode of action of S-adenosyl-L-methionine (SAMe) infusions in elderly subjects, utilizing EEG mapping and psychometry.
    Saletu B; Anderer P; Linzmayer L; Semlitsch HV; Lindeck-Pozza E; Assandri A; di Padova C; Saletu-Zyhlarz GM
    J Neural Transm (Vienna); 2002 Dec; 109(12):1505-26. PubMed ID: 12486491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clovoxamine and fluvoxamine-2 biogenic amine re-uptake inhibiting antidepressants: quantitative EEG, psychometric and pharmacokinetic studies in man.
    Saletu B; Grünberger J; Rajna P; Karobath M
    J Neural Transm; 1980; 49(1-2):63-86. PubMed ID: 6777458
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Classification and determination of pharmacodynamics of a new antihypoxidotic drug, vinconate, by pharmaco-EEG and psychometry.
    Saletu B; Grünberger J; Linzmayer L; Wittek R
    Arch Gerontol Geriatr; 1984 Jul; 3(2):127-46. PubMed ID: 6476974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative bioavailability studies with a new mixed-micelles solution of diazepam utilizing radioreceptor assay, psychometry and EEG brain mapping.
    Saletu B; Anderer P; Kinsperger K; Grünberger J; Sieghart W
    Int Clin Psychopharmacol; 1988 Oct; 3(4):287-323. PubMed ID: 3235816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.